Sohn, Minji
Dietrich, Johannes W.
Nauck, Michael A.
Lim, Soo
Article History
Received: 13 April 2023
Accepted: 2 June 2023
First Online: 28 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: M.A.N. has been member on advisory boards or has consulted with Boehringer-Ingelheim, Berlin-Chemie/ Menarini, Eli Lilly & Co., Merck Sharp & Dohme, Novo Nordisk, Shou-Ti/Gasherbrum, Regor Pharmaceuticals, Sun Pharma. He has received grant support from Merck Sharp & Dohme and Novo Nordisk. He has also served on the speakers’ bureau of Berlin-Chemie/ Menarini, Eli Lilly & Co., Medical Learning Institute, Medscape, Merck Sharp & Dohme, Novo Nordisk, Sanofi, and Sun Pharma. S.L. has been a member of advisory boards, or has consulted, for Merck, Sharp & Dohme, and Novo Nordisk. He has received grant support from AstraZeneca, Merck, Sharp & Dohme, and Astellas. He has also served on the speakers’ bureau of AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Merck, Sharp & Dohme, and Novo Nordisk.